Johnson & Johnson

Johnson & Johnson PEG

The PEG Ratio (Price/Earnings-to-Growth) of Johnson & Johnson (JNJ) as of Oct 18, 2026 is 1.53. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was 2.91 — a change of -47.52% (lower).

PEG

1.53

YoY

-47.52%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Johnson & Johnson is 2025 1.53 . PEG Ratio (Price/Earnings-to-Growth) of Johnson & Johnson was 2024 2.91 . It decreases by -47.52% lower compared to the previous year.

The Johnson & Johnson PEG history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PEG
Date
PEG
Jan 1, 2018
2.68 USD
Jan 1, 2019
2.71 USD
Jan 1, 2020
2.78 USD
Jan 1, 2021
1.96 USD
Jan 1, 2022
2.28 USD
Jan 1, 2023
1.17 USD
Jan 1, 2024
2.91 USD
Jan 1, 2025
1.53 USD
The Johnson & Johnson PEG history
YEARPEGYoY
1.53-47.52%
2.91+149.91%
1.17-48.96%
2.28+16.37%
1.96-29.52%
2.78+2.75%
2.71+1.18%
2.68-91.50%
31.52+1,172.31%
2.48-6.84%
2.66+5.93%
2.51—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Johnson & Johnson Stock analysis

What does Johnson & Johnson do? Johnson & Johnson is an American company that was founded in 1886 by the brothers Robert, James, and Edward Johnson. The company is headquartered in New Brunswick, New Jersey, USA and is now an internationally operating company with more than 130,000 employees worldwide. The history of Johnson & Johnson began with the production of medical bandages. In 1887, the first self-adhesive wound plaster was invented and patented. In the following years, the product range was significantly expanded and now includes a wide range of health products. This includes pharmaceuticals, medical devices, hygiene products, personal care products, and baby products. The business model of Johnson & Johnson is to improve the lives of people worldwide. The company places great importance on innovation, quality, and sustainability. With its long-standing experience and expertise in the healthcare industry, Johnson & Johnson is able to understand the needs of customers and offer products tailored to their specific needs. Johnson & Johnson is now active in three main business areas: Consumer Health, Medical Devices and Diagnostics, and Pharmaceuticals. Within these business areas, there are a variety of brands and products that are among the most well-known in the world. The Consumer Health division of Johnson & Johnson is focused on the production of health and personal care products for consumers. Some well-known brands in this area include Listerine, Johnson's Baby, Neutrogena, and Nicorette. The company offers a wide range of products, from cold and allergy medications to skincare products and toothpastes. Medical Devices and Diagnostics is another major business area of Johnson & Johnson. The company is a leading provider of medical devices and diagnostic products worldwide. Products in this area include surgical systems, implantable devices, diagnostic tests, and imaging devices. Well-known brands in this area include Ethicon, Depuy Synthes, and Cordis. Pharmaceuticals is the third major business area of Johnson & Johnson. The company develops and produces innovative pharmaceuticals for the treatment of diseases such as cancer, diabetes, heart disease, and neurological disorders. Some well-known brands in this area include Remicade, Invega, and Zytiga. Johnson & Johnson is also known for its commitment to sustainability and corporate social responsibility. The company is committed to having a positive impact on the environment and the communities in which it operates. For example, Johnson & Johnson aims to reduce its CO2 emissions by 60% by 2030. Overall, Johnson & Johnson is a leading healthcare company focused on providing innovative and high-quality products that improve the lives of people worldwide. With a wide range of brands and products in various business areas, the company is well positioned to continue to be successful in the future. Johnson & Johnson is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Johnson & Johnson stock

PEG Ratio (Price/Earnings-to-Growth) of Johnson & Johnson is 1.53 in 2025.

PEG Ratio (Price/Earnings-to-Growth) of Johnson & Johnson changed from 2.91 to 1.53, representing a -47.52% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Johnson & Johnson since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Johnson & Johnson with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Johnson & Johnson

All Key Metrics — Johnson & Johnson